Efficacy of intravenous glucose for preventing postoperative nausea and vomiting after abdominal hysterectomy under general anesthesia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

TCTR

Registry ID

TCTR20180722003

Enrollment

110

Registered

2018-07-22

Start date

2018-07-23

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative nausea and vomiting

Interventions

Use 5%DNSS as a maintenance fluid during anesthesia,Use NSS as a maintenance fluid during anesthesia

Experimental Drug,Experimental Drug

5%DNSS group,NSS group

Eligibility

Sex/Gender

Female

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Female status ASA I or II Age 18_65 years Scheduled for abdominal hysterectomy under general anesthesia In form consent

Exclusion criteria

Exclusion criteria: - Type I and II Diabetes Mellitus or impaired fasting glucose or impaired glucose tolerance - Preanesthetic blood glucose > 200 mg/dL or Point-of-Care Testing (POCT) of blood glucose > 180 mg/dL - Heart failure - Acute coronary syndrome (Evidence from physical examination and review from medical records) - Moderate renal insufficiency/renal failure - Recent receiving antiemetic - Steroid use - Pregnancy - EKG showed any arrhythmia or patient that on cardiac pacemaker

Design outcomes

Primary

Measure	Time frame
To evaluate the capability of iv glucose during maintenance of anesthesia After finish surgery Incidence of ponv at recovery room	—

Secondary

Measure	Time frame
Compare time to first dose of antiemetic, amount of antiemetic use, length of hospital stay After finish surgery Minutes	—

Countries

Thailand

Contacts

Public ContactThadakorn Tantisarasart

Prince of Songkla university

Thadakorn.bee@gmail.com0814782248

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026